The healthcare management software developer, previously backed by GV and Ascension Ventures, has taken its overall funding past $900m.
Olive, a US-based healthcare management software producer backed by internet and technology group Alphabet, completed a $400m funding round yesterday valuing it at $4bn.
The round was led by investment firm Vista Equity Partners and also featured venture capital firm Base10 Partners’ Advancement Initiative. It took the overall funding raised by the company to $902m.
Founded in 2012 as CrossChx, Olive offers artificial intelligence-powered software which enables hospitals and healthcare providers to automate administrative workflows, monitor their performance and identify…
